212 related articles for article (PubMed ID: 14566201)
1. Treatment of panic disorder: focus on paroxetine.
Pollack MH; Doyle AC
Psychopharmacol Bull; 2003; 37 Suppl 1():53-63. PubMed ID: 14566201
[TBL] [Abstract][Full Text] [Related]
2. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
[TBL] [Abstract][Full Text] [Related]
3. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine in panic disorder: clinical management and long-term follow-up.
Dannon PN; Lowengrub K; Iancu I; Kotler M
Expert Rev Neurother; 2004 Mar; 4(2):191-8. PubMed ID: 15853560
[TBL] [Abstract][Full Text] [Related]
5. Efficacy studies of paroxetine in panic disorder.
Lydiard RB; Steiner M; Burnham D; Gergel I
Psychopharmacol Bull; 1998; 34(2):175-82. PubMed ID: 9640997
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine treatment of generalized anxiety disorder.
Sheehan DV; Mao CG
Psychopharmacol Bull; 2003; 37 Suppl 1():64-75. PubMed ID: 14566202
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
8. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
Schruers K; Griez E
J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine: a review of clinical experience.
Dunner D; Kumar R
Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
[TBL] [Abstract][Full Text] [Related]
10. The long-term treatment of panic disorder.
Davidson JR
J Clin Psychiatry; 1998; 59 Suppl 8():17-21; discussion 22-3. PubMed ID: 9707158
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of paroxetine with clocapramine in panic disorder.
Saito M; Miyaoka H
Psychiatry Clin Neurosci; 2007 Aug; 61(4):449. PubMed ID: 17610675
[No Abstract] [Full Text] [Related]
12. Efficacy and tolerability of controlled-release paroxetine.
Golden RN
Psychopharmacol Bull; 2003; 37 Suppl 1():176-86. PubMed ID: 14566210
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacotherapy of panic disorder].
Bougerol T; Farisse J
Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].
Mosolov SN; Smulevich AB; Nuller IuL; Grigor'evskikh VS; Kostiukova EG; Kuzavkova MV; Koliutskaia EV; Andriushchenko AV; Zelenina EV; Kosinskiĭ VP; Kozlovskiĭ VL; Bykov SI; Pererva IG
Ter Arkh; 2000; 72(10):16-23. PubMed ID: 11220870
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants in panic disorder.
Wade AG
Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S13-7. PubMed ID: 10471168
[TBL] [Abstract][Full Text] [Related]
18. [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
Reznik AM; Arbuzov AL; Khurbatova IG
Voen Med Zh; 2007 Jan; 328(1):38-43. PubMed ID: 17436713
[No Abstract] [Full Text] [Related]
19. Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.
Perna G; Favaron E; Di Bella D; Bussi R; Bellodi L
Neuropsychopharmacology; 2005 Dec; 30(12):2230-5. PubMed ID: 16034444
[TBL] [Abstract][Full Text] [Related]
20. Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.
Marchesi C; De Panfilis C; Cantoni A; Fontò S; Giannelli MR; Maggini C
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1240-5. PubMed ID: 16678956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]